Australian-New Zealand Clinical Trial: Clinical registry of focal irreversible electroporation in men with biopsy confirmed low-intermediate risk prostate cancer

Australia, Oct. 27 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘Clinical registry of focal irreversible electroporation in men with biopsy confirmed low-intermediate risk prostate cancer’. The following are the other relevant details related to the trial:

Trial ID: 392243

Submit Date: 8/7/26 14:29

Study Type: Observational

Intervention: Participants in this research registry will be recruited from the population of men receiving focal irreversible electroporation (IRE) for low to intermediate risk prostate cancer as part of clinical care as approved by local clinical governance. Participants will be followed up at regular intervals with their clinical data and Patient ...